A recurrent ZP1 variant is responsible for oocyte maturation defect with degenerated oocytes in infertile females.


Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
07 2022
Historique:
revised: 08 04 2022
received: 19 01 2022
accepted: 19 04 2022
pubmed: 24 4 2022
medline: 16 6 2022
entrez: 23 4 2022
Statut: ppublish

Résumé

A female factor is present in approximately 70% of couple infertility, often due to ovulatory disorders. In oocyte maturation defect (OMD), affected patients have a primary infertility with normal menstrual cycles but produce no oocyte, degenerated (atretic) or abnormal oocytes blocked at different stages of maturation. Four genes have so far been associated with OMD: PATL2, TUBB8, WEE2, and ZP1. In our initial study, 6 out of 23 OMD subjects were shown to carry the same PATL2 homozygous loss of function variant and one patient had a TUBB8 truncating variant. Here, we included four additional OMD patients and reanalyzed all 27 subjects. In addition to the seven patients with a previously identified defect, five carried the same deleterious homozygous ZP1 variant (c.1097G>A; p.Arg366Gln). All the oocytes from ZP1-associated patients appeared shriveled and dark indicating that the abnormal ZP1 protein induced oocyte death and degeneration. Overall ZP1-associated patients had degenerated or absent oocytes contrary to PATL2-associated subjects who had immature oocytes blocked mainly at the germinal vesicle stage. In this cohort of North African OMD patients, whole exome sequencing permitted to diagnose 44% of the patients studied and to identify a new frequent ZP1 variant.

Identifiants

pubmed: 35460069
doi: 10.1111/cge.14144
pmc: PMC9327729
doi:

Substances chimiques

TUBB8 protein, human 0
Tubulin 0
ZP1 protein, human 0
Zona Pellucida Glycoproteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

22-29

Informations de copyright

© 2022 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.

Références

Development. 2001 Apr;128(7):1119-26
pubmed: 11245577
J Assist Reprod Genet. 2019 Apr;36(4):741-747
pubmed: 30778819
N Engl J Med. 2014 Mar 27;370(13):1220-6
pubmed: 24670168
Fertil Steril. 2011 Aug;96(2):e125-30
pubmed: 21683950
Am J Hum Genet. 2017 Oct 5;101(4):609-615
pubmed: 28965849
Hum Reprod. 2018 Jul 1;33(7):1364-1369
pubmed: 29912377
Nat Genet. 1995 Feb;9(2):152-9
pubmed: 7719342
Am J Hum Genet. 1996 Sep;59(3):633-43
pubmed: 8751865
Am J Hum Genet. 2018 Apr 5;102(4):649-657
pubmed: 29606300
Int J Dev Biol. 2012;56(10-12):833-9
pubmed: 23417405
Hum Reprod. 2021 Feb 18;36(3):693-701
pubmed: 33332558
Biol Reprod. 2019 Sep 1;101(3):549-566
pubmed: 31077289
Nat Genet. 2007 May;39(5):661-5
pubmed: 17435757
Biochim Biophys Acta. 1999 Oct 28;1447(2-3):303-6
pubmed: 10542331
Clin Genet. 2020 May;97(5):787-788
pubmed: 31909477
Genes (Basel). 2020 Apr 01;11(4):
pubmed: 32244758
EMBO Mol Med. 2018 May;10(5):
pubmed: 29661911
J Assist Reprod Genet. 2020 Nov;37(11):2853-2860
pubmed: 32829425
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Fertil Steril. 2017 Jun;107(6):1364-1369
pubmed: 28577617
Cell Mol Immunol. 2016 Jan;13(1):73-81
pubmed: 25578313
Hum Mutat. 2019 Nov;40(11):2001-2006
pubmed: 31292994
Genome Res. 2004 Apr;14(4):528-38
pubmed: 15059993
J Assist Reprod Genet. 2021 Jan;38(1):251-259
pubmed: 33140178
Mol Genet Genomic Med. 2020 Jul;8(7):e1269
pubmed: 32329253
Bioinformatics. 2018 Sep 1;34(17):i884-i890
pubmed: 30423086
J Cell Mol Med. 2020 Aug;24(15):8557-8566
pubmed: 32573113
J Assist Reprod Genet. 2020 Sep;37(9):2151-2157
pubmed: 32556881
Annu Rev Biochem. 2005;74:83-114
pubmed: 15952882
J Biol Chem. 2008 Sep 5;283(36):24285-9
pubmed: 18539589
Hum Reprod. 2019 Nov 1;34(11):2201-2207
pubmed: 31734689
Bioinformatics. 2014 Sep 1;30(17):2503-5
pubmed: 24812344
Hum Reprod. 2018 Jun 1;33(6):1183-1190
pubmed: 29697801
Hum Reprod. 2005 Jun;20(6):1578-85
pubmed: 15860499
N Engl J Med. 2016 Jan 21;374(3):223-32
pubmed: 26789871
Hum Reprod Update. 2015 Jul-Aug;21(4):427-54
pubmed: 25744083
Cells. 2020 Mar 09;9(3):
pubmed: 32182827
Clin Genet. 2022 Jul;102(1):22-29
pubmed: 35460069
Mol Hum Reprod. 1996 Nov;2(11):889-94
pubmed: 9237231
Cell. 2010 Oct 29;143(3):404-15
pubmed: 20970175
PLoS Genet. 2013 Mar;9(3):e1003363
pubmed: 23555282
Mutat Res. 2019 Jan;813:46-50
pubmed: 30611916
Nat Methods. 2018 Aug;15(8):591-594
pubmed: 30013048
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Clin Pathol. 2022 Mar;75(3):201-204
pubmed: 33461974
Am J Hum Genet. 2017 Sep 7;101(3):459-465
pubmed: 28886344
Annu Rev Genomics Hum Genet. 2000;1:225-49
pubmed: 11701630
Am J Hum Genet. 2018 Sep 6;103(3):400-412
pubmed: 30122540
Reprod Biomed Online. 2017 Aug;35(2):132-138
pubmed: 28596003

Auteurs

Corinne Loeuillet (C)

INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Univ. Grenoble Alpes, Grenoble, France.

Magali Dhellemmes (M)

INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Univ. Grenoble Alpes, Grenoble, France.

Caroline Cazin (C)

INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Univ. Grenoble Alpes, Grenoble, France.
CHU Grenoble Alpes, UM GI-DPI, Grenoble, France.
Département de Génétique Moléculaire, Laboratoire Eurofins Biomnis, Lyon, France.

Zine-Eddine Kherraf (ZE)

INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Univ. Grenoble Alpes, Grenoble, France.
CHU Grenoble Alpes, UM GI-DPI, Grenoble, France.

Selima Fourati Ben Mustapha (S)

Polyclinique les Jasmins, Centre d'Aide Médicale à la Procréation, Centre Urbain Nord, Tunis, Tunisia.

Raoudha Zouari (R)

Polyclinique les Jasmins, Centre d'Aide Médicale à la Procréation, Centre Urbain Nord, Tunis, Tunisia.

Nicolas Thierry-Mieg (N)

CNRS, UMR5525, TIMC, Univ. Grenoble Alpes, Grenoble, France.

Christophe Arnoult (C)

INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Univ. Grenoble Alpes, Grenoble, France.

Pierre F Ray (PF)

INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Univ. Grenoble Alpes, Grenoble, France.
CHU Grenoble Alpes, UM GI-DPI, Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH